Cell Expansion Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034

The process of cultivating isolated cells for several generations to obtain the required cell count for a patient's regenerative response is referred to as cell expansion.

This procedure uses culture media to supply nutrients and eliminate accumulated metabolites, along with serial passages in closed culture vessels. The type of cell and growth rate determine the precise timing and the required number of passages.

MARKET OVERVIEW

The cell expansion market is valued at approximately USD 12.7 billion in 2023 and is projected to reach USD 50.16 billion by 2034 exhibiting a compound annual growth rate (CAGR) of 13.3% during the forecast period of 2024-2034. It is essential for generating the appropriate numbers of cells for scientific study, medicinal uses, and industrial procedures.

GROWTH DRIVERS

The prevalence of chronic diseases, such as cancer and cardiovascular diseases, is increasing worldwide, which necessitates advanced therapeutic solutions like cell-based therapies. According to National Center for Biotechnology Information, the number of people in the United States aged 50 and older is expected to rise by 61.11% from 137.25 million in 2020 to 221.13 million in 2050. From 71.522 million in 2020 to 142.66 million in 2050, the population of 50 years and above having at least one chronic illness is predicted to rise by 99.5%.

The efficiency and effectiveness of cell culture processes have been significantly improved by advances in bioprocessing technologies, which has consequently increased its market demand. For instance, in September 2022, Terumo BCT launched its Quantum Flex Cell Expansion System, a bioreactor platform that assists in the process development and commercial manufacturing of cell and gene therapies.

MARKET SEGMENTATION:

By Product -

·         Consumables

o   Reagents

o   Media

o   Serums

o   Other Consumables

·         Cultural Flask and Accessories

o   Tissue Culture Flasks

o   Bioreactor Accessories

o   Other Flask and Accessories

·         Instruments

o   Automated Cell Expansion Systems

o   Cell Counters

o   Centrifuges

o   Bioreactors

o   Other Instruments

By Cell Type –

·         Human Cells

o   Stem Cell

o   Differentiated Cell

·         Animal Cells

o   Chinese Hamster Ovary Cells

o   Mouse Embryonic Stem Cells

By Application –

·         Biopharmaceuticals

·         Tissue Culture & Engineering

·         Vaccine Production

·         Drug Development

·         Gene Therapy

·         Cancer Research

·         Stem Cell Research

By End User –

·         Biotechnology & Biopharmaceutical Companies

·         Research Institute

·         Cell Bank

·         Others

By Region -

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa

Cell Expansion Market By Product Segment Review:

The consumables segment dominated the global market, accounting for more than two-fifths of the total revenue share in 2022. The market for consumables in cell expansion is mainly driven by increasing demand for biopharmaceuticals and regenerative medicine. Furthermore, the growing trend of customized medicine and improvements in cell culture techniques are driving demand for specialized consumables made specifically for specific cell types.

Cell Expansion Market By Cell Type Segment Review:

The human cell segment is expected to remain dominant during the forecast period due to exponential increase in research activities of cell-based therapies such as regenerative medicines.

Cell Expansion Market By Application Segment Review:

The biopharmaceutical segment accounted for the largest revenue share in the global market. The market for cell expansion for this segment is growing largely due to rise in chronic diseases and the need for personalized medicine.

Cell Expansion Market By End User Segment Review:

The biotechnology & biopharmaceutical companies' segment was the dominant market segment in 2022, accounting for around two-fifth of the global revenue. The growth of cell-based therapeutics within the healthcare industry is a significant factor behind this dominance.

Cell Expansion Market By Region Segment Review:

The market is anticipated to be dominated by North America, which contributed more than one-third of worldwide revenue. The market in this region is driven by substantial funding initiatives from government agencies and the presence of key players in the region.

Cell Expansion Market Regional Synopsis:

The market share of North America in cell expansion is the highest. The development of regenerative medicine and cellular therapy products, as well as the rapid production of stem cells due to significant funding initiatives from government agencies, are some of the reasons for this dominance.

Europe is another significant market for cell expansion with a strong emphasis on biotechnology and pharmaceutical research and development. Investment in cell expansion technology has been stimulated by the regulatory frameworks that streamline the approval process for novel medicines.

Over the course of the projection period, the Asia Pacific region is anticipated to increase at the highest rate. Increasing attempts by regional biotechnology and pharmaceutical companies focused on creating and marketing cellular medicines are the driving force behind this quick expansion.

The market for cell expansion is progressively growing in Latin America because of rising infrastructure expenditures for healthcare and rising patient and healthcare professional awareness of cutting-edge treatment choices.

The Middle East & Africa region shows potential for growth within the cell expansion market because of increased government spending on biotechnology and healthcare infrastructure.

Cell Expansion Market Key Challenges:

Operational costs in the cell expansion industry are significant due to the requirement for specialized equipment, qualified workers, and adherence to strict quality control procedures. These high operational costs are a major challenge for manufacturers as it is likely to restrict financial flexibility and prevent investment in research and development or marketing initiatives.

Another major obstacle in the cell expansion market is the navigation of the regulatory environment. The regulation of cell-based therapies and products differs between regions, which often complicates compliance efforts. Companies are required to invest time and resources in understanding and adhering to these regulations, which frequently delay their product launches and increase their operational costs.

Cell Expansion Competitive Landscape:

The global market for cell expansion is characterized by a competitive environment that includes numerous established players striving for innovation practices while navigating regional dynamics.

Companies are implementing several strategic initiatives, including partnerships, collaborations, mergers and acquisitions, and the introduction of new products to enhance their capabilities in research and development and improve their competitive position. For instance, in March 2023, TrakCel and Lonza merged their platforms to Combine their cell and gene therapy manufacturing and orchestration solutions.

Cell Expansion Key Players:

·         Thermo Fishers

·         Terumo Corporation

·         Danaher Corporation

·         Sartorius AG

·         Corning Incorporated

·         Repligen Corporation

·         Takara Bio Inc.

·         upcyte technologies GmbH

·         STEMCELL Technologies

·         Cytiva

·         Other Key & Niche Players